This article is more than 5 years old. Information may no longer be current.

Coronado to initiate direct Canadian sales of pneumatic trabeculoplasty

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

FOUNTAIN HILLS, Ariz. — Coronado Industries will directly market its device for performing pneumatic trabeculoplasty in Canada, the company announced.

The decision follows Health Canada's June 2006 grant of a medical device license and marks Coronado's first attempt at direct marketing of a medical device, according to a press release.

"Given the close proximity of key Canadian population centers, we believe that our plans offer the potential to generate near-term revenue for the company," said John W. Sharkey, PhD, president of Ophthalmic International, a wholly owned subsidiary of Coronado.